Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.

Autor: Marker KM; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California.; Division of Epidemiology, School of Public Health, University of California Berkeley, Berkeley, California., Zavala VA; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California., Vidaurre T; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Lott PC; UC Davis Genome Center, University of California, Davis, Davis, California., Vásquez JN; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Casavilca-Zambrano S; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Calderón M; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Abugattas JE; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Gómez HL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Fuentes HA; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Picoaga RL; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Cotrina JM; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Neciosup SP; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Castañeda CA; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Morante Z; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Valencia F; Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Torres J; Unidad de Investigación en Enfermedades Infecciosas, Instituto Mexicano del Seguro Social; México City, México., Echeverry M; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia., Bohórquez ME; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia., Polanco-Echeverry G; UC Davis Genome Center, University of California, Davis, Davis, California., Estrada-Florez AP; UC Davis Genome Center, University of California, Davis, Davis, California.; Grupo de Citogenética, Filogenia y Evolución de Poblaciones, Facultades de Ciencias y Facultad de Ciencias de la Salud, Universidad del Tolima, Ibagué, Colombia., Serrano-Gómez SJ; Grupo de Investigación en Biología del Cáncer, Instituto Nacional de Cancerología, Bogotá, Colombia., Carmona-Valencia JA; Dinamica IPS, Medellín, Colombia., Alvarado-Cabrero I; Hospital de Oncología de Centro Médico Nacional Siglo XXI, México City, México., Sanabria-Salas MC; Subdirección de Investigaciones - Instituto Nacional de Cancerología, Bogotá, Colombia., Velez A; Dinamica IPS, Medellín, Colombia.; Hospital Pablo Tobon Uribe, Medellín, Colombia., Donado J; Hospital Pablo Tobon Uribe, Medellín, Colombia., Song S; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California., Cherry D; Department of Medicine, University of California San Diego, San Diego, California., Tamayo LI; Department of Public Health Sciences, University of Chicago, Chicago, Illinois., Huntsman S; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California., Hu D; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California., Ruiz-Cordero R; Department of Pathology, University of California, San Francisco, California., Balassanian R; Department of Pathology, University of California, San Francisco, California., Ziv E; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California., Zabaleta J; Stanley S. Scott Cancer Center, LSUHSC, New Orleans, Louisiana.; Department of Pediatrics, LSUHSC, New Orleans, Louisiana., Carvajal-Carmona L, Fejerman L; Division of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, California. laura.fejerman@ucsf.edu.; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California.

Publikováno v: Cancer research [Cancer Res] 2020 May 01; Vol. 80 (9), pp. 1893-1901. Date of Electronic Publication: 2020 Apr 03.

Genomic ancestry and cancer among Latin Americans.

Autor: Ruíz-Patiño A; Clinical Genetics, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia.; Foundation for Clinical and Applied Cancer Research - FICMAC, Bogotá, Colombia.; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia., Rojas L; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Zuluaga J; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Arrieta O; Instituto Nacional de Cancerología -INCaN, Mexico City, Mexico., Corrales L; Thoracic Oncology Unit, Centro de Investigación y Manejo del Cáncer (CIMCA), San José, Costa Rica., Martín C; Thoracic Oncology Unit, Instituto Alexander Fleming, Buenos Aires, Argentina., Franco S; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Breast Cancer Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Raez L; Oncology Department, Memorial Cancer Institute (MCI), Memorial Healthcare System, Miami, FL, USA., Rolfo C; Center for Thoracic Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Sánchez N; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia.; Institute of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia., Cardona AF; GIGA/TERA Research Group, CTIC/Universidad El Bosque, Bogotá, Colombia. acardona@fctic.org.; Thoracic Oncology Unit, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. acardona@fctic.org.; Institute of Research, Science and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Bogotá, Colombia. acardona@fctic.org.; Direction of Research and Education, Luis Carlos Sarmiento Angulo Cancer Treatment and Research Center (CTIC), Cra. 14 #169-49, Bogotá, Colombia. acardona@fctic.org.

Publikováno v: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Aug; Vol. 26 (8), pp. 1856-1871. Date of Electronic Publication: 2024 Apr 06.

Association of genetic ancestry with HER2, GRB7 AND estrogen receptor expression among Colombian women with breast cancer.

Autor: Rey-Vargas, Laura, María Bejarano-Rivera, Lina, Carlos Mejia-Henao, Juan, Sua, Luz F., Faustino Bastidas-Andrade, Jhon, Andrés Ossa, Carlos, Dary Gutiérrez-Castañeda, Luz, Fejerman, Laura, Sanabria-Salas, María Carolina, Serrano-Gómez, Silvia J.

Publikováno v: Frontiers in Oncology; 12/22/2022, Vol. 12, p1-12, 12p

Clinical Informatics Approaches to Understand and Address Cancer Disparities.

Autor: Chaunzwa, Tafadzwa L., del Rey, Maria Quiles, Bitterman, Danielle S.

Publikováno v: Yearbook of Medical Informatics; 2022, Vol. 31 Issue 1, p121-130, 10p

Homodimer ^99m Tc-HYNIC-E(SSSLTVPWY) 2 peptide improved HER2-overexpressed tumor targeting and imaging.

Autor: Ebrahimi F; Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran., Noaparast Z; Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran., Abedi SM; Department of Radiology and Nuclear Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran., Hosseinimehr SJ; Department of Radiopharmacy, Faculty of Pharmacy, Mazandaran University of Medical Sciences, Sari, Iran. sjhosseinim@yahoo.com.

Publikováno v: Medical oncology (Northwood, London, England) [Med Oncol] 2022 Sep 29; Vol. 39 (12), pp. 204. Date of Electronic Publication: 2022 Sep 29.